US · Healthcare

Briacell Therapeutics Corp (BCTX)

Biotechnology

Briacell Therapeutics Corp (BCTX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BCTX

P/E ratio

25.00

Briacell Therapeutics Corp (BCTX) — FAQ

What is BCTX's P/E ratio?

The price-to-earnings (P/E) ratio for Briacell Therapeutics Corp (BCTX) is 25.00 (data as of 2026-05-23).

Does Briacell Therapeutics Corp pay a dividend?

Dividend yield is not available in the current snapshot for Briacell Therapeutics Corp (BCTX). Check the MyAverix Finance app for the latest dividend data.

What sector is Briacell Therapeutics Corp in?

Briacell Therapeutics Corp (BCTX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BCTX listed on?

BCTX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)